Skip to main content

SSCP

Twitter Instagram Snapchat
0
Your Cart
No products in the cart.

BTK Inhibitors in CLL: Cardiovascular Risk, Bleeding, and Drug–Drug Interactions

  1. Home
  2. BTK Inhibitors in CLL: Cardiovascular Risk, Bleeding, and Drug–Drug Interactions
SS
SSCP Support
/
August 25, 2026

BTK Inhibitors in CLL: Cardiovascular Risk, Bleeding, and Drug–Drug Interactions

00
0 Enrolled
Vaccine Science

 

The Saudi Society of Clinical Pharmacy (SSCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

Course Content

BTK Inhibitors in CLL: Cardiovascular Risk, Bleeding, and Drug–Drug Interactions

  • BTK Inhibitors in CLL: Cardiovascular Risk, Bleeding, and Drug–Drug Interactions

Evaluations Form

Free
Free access this course
  • Intermediate
  • 0 Total Enrolled
  • August 25, 2026 Last Updated
  • Certificate of completion
Durations:
Lectures: 1
Students: Max
Level: Intermediate
Language: English
Certificate: Yes